Jul 29, 2021

Craft Ventures Leads ConverseNow's $15M Series A

Paul Sethi

Read the coverage on TechCrunch

Subscribe to our newsletter

Signup to get blog posts with our investments, theses and important announcements from 2048 Ventures.

Recent posts

Browse all articles

Theses

Jul 16, 2025

Our Thesis on Molecular Biosensors

We see two inevitabilities: the rise of biosensors in clinical trials to enable real-world endpoints, and the shift toward non-invasive, continuous monitoring that decentralizes care and replaces traditional lab tests.



Investments

Jul 9, 2025

Our Investment in Kascaid

Kascaid is building an interstitial fluid biosensor for immune monitoring starting in clinical trials, where more convenient and frequent sampling can reduce dropout and richer data can enable smaller, faster studies.



Investments

Jun 13, 2025

Our Investment in Nimbus Health

Nimbus Health is building the future of pulmonology.



Browse all articles